Lipid and glucide sources in artificial nutrition

  • Donatella Noè
  • Paola Lanzi
  • Elisabetta Bergamaschi
Review

Abstract

Lipids and glucides, the energetic compounds in artificial nutrition solutions, are not only “fuel” but possess other biologic functions which may influence disease evolution. Energy-yielding solutions should cover the patient’s metabolic needs but should also limit any inflammatory and oxidative stress or impairment of the immune system. This paper provides a concise overview of the clinical and metabolic properties of the most common energetic substrates employed both in enteral and parenteral nutrition.

Keywords

Lipids Glucides Parenteral and enteral nutrition Clinical effects 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stapleton RD, Jones N, Heyland DK (2007) Feeding critically ill patients: what is the optimal amount of energy? Crit Care Med 35:S535–S540CrossRefGoogle Scholar
  2. 2.
    Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367CrossRefGoogle Scholar
  3. 3.
    Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041–2047CrossRefGoogle Scholar
  4. 4.
    Van den Berghe G, Wilmer A, Milants I et al (2006) Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55:3151–3159CrossRefGoogle Scholar
  5. 5.
    Garber AJ, Moghissi ES, Bransome ED Jr et al (2004) American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10:77–82Google Scholar
  6. 6.
    Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139CrossRefGoogle Scholar
  7. 7.
    Wiener S, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300:933–944CrossRefGoogle Scholar
  8. 8.
    Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327CrossRefGoogle Scholar
  9. 9.
    Wahed M, Geoghenan M, Powel-Tuck J (2007) Novel substrates. Eur J Gastroenterol Hepatol 19:365–370CrossRefGoogle Scholar
  10. 10.
    Elia M, Engfer M, Green C, Silk D (2008) Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther 27:120–145CrossRefGoogle Scholar
  11. 11.
    Elia M, Ceriello A, Laube H (2005) Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes. A systematic review and meta-analysis. Diabetes Care 28:2267–2279CrossRefGoogle Scholar
  12. 12.
    American Diabetes Association (2008) Nutrition Recommendations and Intervention for Diabetes. A position statement of the American Diabetes Association. Diabetes Care 31:S61–S78CrossRefGoogle Scholar
  13. 13.
    Volman J, Ramakers J, Plat J (2008) Dietary modulation of immune function by β-glucans. Physiol Behav 94:276–284CrossRefGoogle Scholar
  14. 14.
    Wanten GJ, Calder P (2007) Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 85:1171–1184Google Scholar
  15. 15.
    Driscol DF (2006) Lipid injectable emulsions: 2006. Nutr Clin Pract 21:381–386CrossRefGoogle Scholar
  16. 16.
    Wanten G (2006) An update on parenteral lipids and immune function: only smoke, or is there any fire? Curr Opin Clin Nutr Metab Care 9:79–83CrossRefGoogle Scholar
  17. 17.
    Wirtitsch M, Wessner B, Spittler A et al (2007) Effect of different lipid emulsions on the immunological function in humans: a systematic review with meta-analysis. Clin Nutr 26:302–313CrossRefGoogle Scholar
  18. 18.
    Furukawa K, Yamamori H, Takagi K et al (2002) Influences of soy bean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition 18:235–240CrossRefGoogle Scholar
  19. 19.
    Heyland DK (2000) Parenteral nutrition in critically ill patients: more harm that good. Proc Nutr Soc 59:457–466Google Scholar
  20. 20.
    Oliveira FL, Rumsey SC, Schlotzer E et al (1997) Triglyceride hydrolysis of soy oil vs fish oil emulsions. JPEN J Parenter Enteral Nutr 21:224–229CrossRefGoogle Scholar
  21. 21.
    Wanten GJ, Naber AH (2004) Cellular and physiological effects of medium-chain triglycerides. Mini Rev Med Chem 4:847–857Google Scholar
  22. 22.
    Van den Berghe G, Wouters P, Weekers F (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367CrossRefGoogle Scholar
  23. 23.
    Sukkar SG, Cella F, Magliano A et al (2006) Medium-term parenteral nutrition (MTPN) with medium/long-chain triglycerides (MCT/LCT) in malnourished patients: effects on nutritional and metabolic parameters. Nutr Ther Metab 24:134–139Google Scholar
  24. 24.
    Waitzberg DL, Torrinhas RS, Jacintho TM (2006) New parenteral lipid emulsions for clinical use. JPEN J Parenter Enteral Nutr 30:351–367CrossRefGoogle Scholar
  25. 25.
    Chambrier C, Lauverjat M, Bouletreau P (2006) Structured triglyceride emulsions in parenteral nutrition. Nutr Clin Pract 21:342–350CrossRefGoogle Scholar
  26. 26.
    Reimund JM, Rahmi G, Escalin G et al (2005) Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition. Aliment Pharmacol Ther 21:445–454CrossRefGoogle Scholar
  27. 27.
    Kelbel I, Wagner F, Wiedeck-Suger H et al (2003) Effects of n-3 fatty acids on immune function: a double blind, randomized trial of fish-oil based infusion in post-operative patients. Clin Nutr 22:59–64CrossRefGoogle Scholar
  28. 28.
    Grimm H, Mertes N, Goeters C et al (2006) Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 45:55–60CrossRefGoogle Scholar
  29. 29.
    Mertes N, Grimm H, Furst P et al (2006) Safety and efficacy of a new parenteral lipid emulsion (SMOFLipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 50:253–259CrossRefGoogle Scholar
  30. 30.
    Zachos M, Tondeur M, Griffiths AM (2007) Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev: CD000542Google Scholar
  31. 31.
    Mayer K, Seeger W (2008) Fish oil in critical illness. Curr Opin Clin Nutr Metab Care 11:121–127CrossRefGoogle Scholar
  32. 32.
    Wild GE, Drozdowski L, Tartaglia C et al (2007) Nutritional modulation of the inflammatory response in inflammatory bowel disease: from the molecular to the integrative to the clinical. World J Gastroenterol 13:1–7Google Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Donatella Noè
    • 1
  • Paola Lanzi
    • 1
  • Elisabetta Bergamaschi
    • 1
  1. 1.UOS Nutrizione Clinica e DietologiaAO San Carlo BorromeoMilanItaly

Personalised recommendations